PARIS — A new report based on research by the Economist Intelligence Unit (EIU) and sponsored by Pfizer Vaccines assesses why, despite the evidence supporting the medical and cost-saving benefits of preventative health care measures, consumers regularly choose not to adopt them. Through interviews with leading international experts, the report reviews the psychological factors affecting consumer and
NEW YORK — Iconic soul singer Patti LaBelle has partnered with Pfizer Inc. in a campaign urging seniors to get vaccinated for pneumococcal pneumonia. Called “All About Your Boom,” the public awareness campaign aims to educate people age 65 and older about the risks of pneumococcal pneumonia and the need to stay up to date
NEW YORK — Pfizer Inc. plans to buy GlaxoSmithKline’s quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for about $130 million. (NYSE: PFE) today announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130 million (€115 million). Pfizer
